Acepodia

About:

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

Website: https://www.acepodia.com

Twitter/X: AcepodiaInc

Top Investors: 8VC, CDIB Capital, DEFTA Partners, Ridgeback Capital, Digital Mobile Venture

Description:

Acepodia is a clinical-stage biotechnology business that is using its proprietary Antibody-Cell Conjugation (ACC) platform technology to produce first-in-class cell treatments to solve gaps in cancer care. Acepodia employs this live-cell compatible chemistry to attach tumor-targeting antibodies directly to a variety of immune cell receptors, enhancing the lock between immune and cancer cells and generating highly specific, potent cell therapies without the need for genetic engineering. Acepodia is committed to immunotherapeutic strategies against oncology – expanding our research, clinical development, and manufacturing capabilities. Acepodia currently has a broad pipeline portfolio, each targeting a different type of cancer.